Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Eli Lilly Comes Out Swinging
The annual J.P. Morgan Healthcare conference in San Francisco concluded last week with very few big deal announcements. In January 2019, Bristol-Myers Squibb (NYSE: BMY) made its $74 billion takeover of Celgene Corporation (NASDAQ: CELG) public just before the conference started. That was quickly followed by Eli Lilly and Company’s (NYSE: LLY) $8 billion deal for Loxo Oncology. This year, Eli Lilly was back in the spotlight with an agreement to acquire Demira, Inc. (NASDAQ: DERM), the largest deal announced in January. The $1.1 billion cash price (13.3x revenue), or $18.75 a share, represents an 86% premium to the 60-day volume-weighted average trading price of Dermira’s stock... Read More »
Health Care M&A Deals, Week Ending January 17, 2020
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price Incyte Corporation License to tafasitamab $750,000,000 Biogen Inc. PF-05251749 $75,000,000 BioNTech AG Neon Therapeutics, Inc. $67,000,000 Axsome Therapeutics, Inc. License to clinical data and AXS-14 $11,000,000 eHealth Acquirer... Read More »
Last-Minute Closings Made for a Busy December
December’s deal volume proved to be a fitting end to a busy year. With 148 deals already reported, the last month of the year easily topped November’s total of 136 (+9%) and even December 2018’s 142 deals (+4%). Deal makers were in a rush to close transactions by the end of the year, obviously. The services sectors benefited the most from this holiday rush, accounting for an unusually high 75% of December’s volume. By contrast, the services side contributed 68% of November’s deal volume and 69% of December 2018’s total. The average share is around 63% over the course of a year A few of the services sectors posted strong gains, year over year. Home Health & Hospice gained 100%, albeit... Read More »
Arosa+LivHOME Bets On New Care Management Platform
Arosa+LivHOME is already on the acquisition trail in the new year. According to our Deal Search Online database, the company reported six transactions in 2019 and is wasting no time to keep growing. In early January, the Bain Capital Double Impact portfolio company purchased Lifecare Innovations, a professional care management services provider. No financial details were disclosed. The acquisition is a step into the care management (CM) market, a growing field in the home health sector. CM aims to help patients navigate the healthcare system and treatment options for disabilities, disease and age-related issues, and with the advent of value-based incentives from CMS, some firms are... Read More »
Anika Therapeutics, Inc. Announces Double Purchase
Anika Therapeutics, Inc. (NASDAQ: ANIK), a medical device company that develops therapeutic products for tissue protection, healing and repair, announced two acquisitions in mid-Januaryto bolster its device portfolio. For a modest sum of $35 million upfront and a potential $60 million in milestones, the company acquired Parcus Medical, LLC, which provides implant and instrumentation products used by surgeons to repair and reconstruct damaged ligaments and tendons due to sports injuries, trauma and disease. The deal will help expand Anika’s offerings into the ambulatory surgical center (ASC) market. Parcus reported $12.5 million in revenue in 2019. Anika also acquired Arthrosurface for $60... Read More »
Fourth Quarter 2019 Health Care Results Were Strong
Fourth quarter 2019 results will turn out to be a strong one. Deals are still being added, but the current total for Q4:19 is 430 transactions. That’s down about 6% compared with the third quarter’s 456 deals and 15% behind the same quarter in 2018, when 504 deals were announced. Some trends emerged in the quarter that bear out what we’re hearing from sources. Deal flow in the Behavioral Health Care sector softened in the fourth quarter, although it didn’t fall into negative territory. This sector has seen years of growth as private equity firms have piled in to build national and regional platforms around addiction treatment and autism programs and services. Autism is still the hottest... Read More »
Health Care M&A Deals, Week Ending January 10, 2020
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Behavioral Health Care Acquirer Target Price The Stepping Stones Group Star of CA N/A Discovery Behavioral Health Associated Behavioral Health Care of Seattle N/A Galen Partners Evolve Treatment Centers N/A Biotechnology Acquirer Target Price Kyorin Pharmaceutical Co., Ltd. Rights to... Read More »
Laboratories, MRI and Dialysis Deals Fared Just Fine in Q4
A few final deals are still rolling in for the last month of 2019, and it seems like the Laboratories, MRI & Dialysis sector fared well. Deal count was down from Q4 2018, 14 this quarter compared to a total of 19 in Q4 2019. However, dollar volume is higher, buoyed by a few large transactions. Cinven and Astorg, two private equity firms, teamed up for the largest transaction of the sector in Q4, purchasing LGC Group for roughly $3.88 billion, according to a report in Private Equity News. LGC provides a range of measurement tools, proficiency testing schemes, supply chain assurance standards, and specialty genomics reagents to the life sciences industry in over 22 countries. KKR (NYSE:... Read More »
2019’s Biggest Healthcare Deals, by Sector
2020 has just begun, which means it’s time to look back at the healthcare M&A landscape of 2019. Just three days into the new year, nearly 1,780 deals are already on the books for 2019. More deals will turn up as we search our many sources, but the number likely won’t top the record of 1,900-plus set in 2018. Thanks to the multi-billion-dollar deals announced in the Biotech and Pharmaceutical sectors, 2019 will set a new spending record. Preliminary data show $399.1 billion was spent on healthcare acquisitions last year, about 20% higher than in 2018. We expect that number to rise as we go through the year and the 10Ks and quarterly reports come out. It’s possible the... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
